The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

40 articles for G Siemeister


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Optimization of allosteric MEK inhibitors. Part 2: Taming the sulfamide group balances compound distribution properties.EBI
Bayer Healthcare
Anthranilic acid amides: a novel class of antiangiogenic VEGF receptor kinase inhibitors.EBI
Novartis Pharma
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction.EBI
Bayer AG
Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity.EBI
Bayer Pharma AG
Changing for the Better: Discovery of the Highly Potent and Selective CDK9 Inhibitor VIP152 Suitable for Once Weekly Intravenous Dosing for the Treatment of Cancer.EBI
Bayer Pharma
BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.EBI
Bayer
Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase.EBI
Bayer
Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor Models.EBI
Bayer
Optimization of allosteric MEK inhibitors. Part 1: Venturing into underexplored SAR territories.EBI
Bayer Healthcare
AMIDE-CONTAINING LONP1 INHIBITOR COMPOUNDS, USES AND METHODSBDB
Pretzel Therapeutics
CRYSTAL FORM OF PYRROLOPYRIMIDINE COMPOUND AND PREPARATION METHOD FOR CRYSTAL FORMBDB
Zhejiang Longcharm Bio-Tech Pharma. Co.
Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amineBDB
Kronos Bio
Substituted [5,6]cyclic-4(3H)-pyrimidinones as anticancer agentsBDB
Zenji Research Laboratories
Imidazolepyridine compounds and uses thereofBDB
Novartis
Tricyclic PI3K inhibitor compounds and methods of useBDB
Genentech
Triaza-spirodecanones as DDR1 inhibitorsBDB
Hoffmann-La Roche
GLS1 inhibitors for treating diseaseBDB
The University of Texas System
Piperidine isoxazole and isothiazole orexin receptor antagonistsBDB
Merck Sharp & Dohme
Cinnoline derivatives useful as CB-1 receptor inverse agonistsBDB
Janssen Pharmaceutica
5-azaindazole compounds and methods of useBDB
F. Hoffmann-La Roche
Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI.BDB
Ataturk University
Design, synthesis, and urease inhibition studies of some 1,3,4-oxadiazoles and 1,2,4-triazoles derived from mandelic acid.BDB
Quaid-I-Azam University
Heat Capacity Changes for Transition-State Analogue Binding and Catalysis with Human 5'-Methylthioadenosine Phosphorylase.BDB
Albert Einstein College of Medicine
3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 deltaBDB
Sanofi
Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereofBDB
Kissei Pharmaceutical
Design, synthesis, biological evaluation, and molecular docking of novel benzopyran and phenylpyrazole derivatives as Akt inhibitors.BDB
Zhejiang University
Selective androgen receptor modulatorsBDB
Radius Health
Heterocyclic derivativesBDB
Novartis
Triazinoindole analogs as potent inhibitors of a-glucosidase: synthesis, biological evaluation and molecular docking studies.BDB
Hazara University
Heterocyclic compounds and uses thereofBDB
Celgene Avilomics Research
Selective glycosidase inhibitors and uses thereofBDB
Simon Fraser University
Bicyclic compounds and their uses as dual c-SRC/JAK inhibitorsBDB
Debiopharm
Histone deacetylase inhibitors, process for preparation and uses thereofBDB
Zhejiang Hisun Pharmaceutical
Macrocyclic inhibitors of hepatitis C virusBDB
Medivir
Urokinase inhibitors, production and use thereofBDB
The Medicines
Stable expression of a synthetic gene for the human motilin receptor: use in an aequorin-based receptor activation assay.BDB
Kosan Biosciences
Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.BDB
Gsk